1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance
Emdal, Kristina B. ; Palacio-Escat, Nicolàs ; Wigerup, Caroline ; Eguchi, Akihiro ; Nilsson, Helén ; Bekker-Jensen, Dorte B. ; Rönnstrand, Lars LU
; Kazi, Julhash U.
LU
; Puissant, Alexandre
and Itzykson, Raphaël
, et al.
(2022)
In Cell Reports
40(6).
- Contribution to journal › Article
- 2019
-
Mark
The role of SRC family kinases in FLT3 signaling
Kazi, Julhash U. LU
and Rönnstrand, Lars
LU
(2019)
In International Journal of Biochemistry and Cell Biology
107.
p.32-37
- Contribution to journal › Scientific review
- 2018
-
Mark
Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation
Marhäll, Alissa LU ; Heidel, Florian ; Fischer, Thomas and Rönnstrand, Lars LU
(2018)
In Annals of Hematology
97(5).
p.773-780
- Contribution to journal › Article
- 2017
-
Mark
Tyrosine 842 in the activation loop is required for full transformation by the oncogenic mutant FLT3-ITD
Kazi, Julhash U. LU
; Chougule, Rohit A.
LU
; Li, Tianfeng
; Su, Xianwei
; Moharram, Sausan A.
LU
; Rupar, Kaja
LU
; Marhäll, Alissa
LU
; Mohiuddin, Gazi
LU
; Sun, Jianmin
LU
and Zhao, Hui
, et al.
(2017)
In Cellular and Molecular Life Sciences
74(14).
p.2679-2688
- Contribution to journal › Article
- 2013
-
Mark
Deregulation of protein phosphatase expression in acute myeloid leukemia
- Contribution to journal › Article